Novel Ligand Specificity of Pituitary Vasopressin Receptors in the Rat
The DOI matches its Crossref record.
Abstract
The ligand specificities of sites binding tritium-labeled arginine vasopressin (3H-AVP) were investigated in membrane preparations of rat anterior pituitary gland and liver. Labeled AVP interacted with high-affinity, low-capacity binding sites in liver as well as in pituitary membrane fractions. Binding displacement studies showed that AVP was a potent ligand for liver (K 1 = 0.23 nM) and pituitary (K 1 = 0.4 nM) receptors. Oxytocin and the antidiuretic (V2) agonist dDAVP had low affinities (K 1 > 10 nM) both for liver and pituitary binding sites. The pressor (V 1) antagonist d(CH2)5Tyr(Me)AVP was equipotent with AVP in liver membranes, but was 1,000-fold less potent on pituitary receptors. Another V 1 antagonist, dPenTyr(Me)AVP, displaced 3H-AVP with K 1 values of 3 and 8 nM from pituitary and liver receptors, respectively. These data are in reasonable agreement with recent studies of the in vitro biological activities of the analogs tested, and suggest that the ligand specificity of rat pituitary AVP receptors is distinct from those of previously characterized V 1, V 2 and oxytocin binding sites in the rat.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Prolactin: structure, function, and regulation of secretion
Freeman, M. E., Kanyicska, B., Lerant, A., & Nagy, G. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.4.1523 · Cited by 2,457
Neuroendocrine pharmacology of stress
Carrasco, G. A., & Van de Kar, L. D. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01285-8 · Cited by 914
Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system
Whitnall, M. H. (1993) · Progress in Neurobiology · doi:10.1016/0301-0082(93)90035-q · Cited by 582
Vasopressin: Behavioral roles of an “original” neuropeptide
Caldwell, H. K., Lee, H.-J., Macbeth, A. H., & Young, W. S. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.10.007 · Cited by 504
“…(s=agonist, i=antagonist where known) except for SRX251 (human) References: 1 Pena et al., 2007a 2 Manning and Sawyer, 1993 3 Saito et al., 1997 4 Antoni, 1984 5 Howl et al., 1993 6 Antoni and Chadio, 1989 7 Guillon et al., 2007 8 Pena et al., 2007b 9 Serradeil-Le Gal et al., 2002b Prog…”
BackgroundMolecular cloning and expression of a rat Via arginine vasopressin receptor
Morel, A., O'Carroll, A.-M., Brownstein, M. J., & Lolaft, S. J. (1992) · Nature · doi:10.1038/356523a0 · Cited by 477
Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor.
Sugimoto, T., Saito, M., Mochizuki, S., Watanabe, Y., Hashimoto, S., & Kawashima, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47129-3 · Cited by 378
Vaccari, C., Lolait, S. J., & Ostrowski, N. L. (1998) · Endocrinology · doi:10.1210/endo.139.12.6382 · Cited by 308
MANNING, M., STOEV, S., CHINI, B., DURROUX, T., MOUILLAC, B., & GUILLON, G. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00437-8 · Cited by 296
Drugs Five Years Later: Desmopressin
RICHARDSON, D. W., & ROBINSON, A. G. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-2-228 · Cited by 272
The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors
Juul, K. V., Bichet, D. G., Nielsen, S., & Nørgaard, J. P. (2014) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00604.2013 · Cited by 156
“V1b receptors are prominent in the anterior pituitary (2) and are involved in adrenocorticotropin hormone secretion and also in cognitive functions in the brain (e.”
BackgroundThe Basic and Clinical Pharmacology of Nonpeptide Vasopressin Receptor Antagonists
Thibonnier, M., Coles, P., Thibonnier, A., & Shoham, M. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.175 · Cited by 146
Oxytocin, vasopressin, and the motivational forces that drive social behaviors
Caldwell, H. K., & Albers, H. E. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2015_390 · Cited by 129
Oxytocin and vasopressin: genetics and behavioral implications
Caldwell, H. K., & Young, W. S. (2006) · Handbook of Neurochemistry and Molecular Neurobiology · doi:10.1007/978-0-387-30381-9_25 · Cited by 113
Young, 3., & Gainer, H. (2003) · Neuroendocrinology · doi:10.1159/000073702 · Cited by 103
The vasopressin 1b receptor and the neural regulation of social behavior
Stevenson, E. L., & Caldwell, H. K. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.11.009 · Cited by 100
“It is also heavily expressed in the corticotrophes of the anterior pituitary gland (Antoni, 1984; Jard et al., 1986), but is also found in the brain.”
Rotondo, F., Butz, H., Syro, L. V., Yousef, G. M., Di Ieva, A., Restrepo, L. M., Quintanar-Stephano, A., Berczi, I., & Kovacs, K. (2016) · Pituitary · doi:10.1007/s11102-015-0703-0 · Cited by 93
Molecular biology of vasopressin receptors
LOLAIT, S. J., O'CARROLL, A., & BROWNSTEIN, M. J. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44688.x · Cited by 87
Salata, R. A., Jarrett, D. B., Verbalis, J. G., & Robinson, A. G. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113382 · Cited by 84
Distribution and developmental changes in vasopressin V2 receptor mRNA in rat brain
Kato, Y., Igarashi, N., Hirasawa, A., Tsujimoto, G., & Kobayashi, M. (1995) · Differentiation · doi:10.1046/j.1432-0436.1995.5930163.x · Cited by 82
WATANABE, T., & ORTH, D. N. (1987) · Endocrinology · doi:10.1210/endo-121-3-1133 · Cited by 80
Engler, D., Redei, E., & Kola, I. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0376 · Cited by 79
Distribution and developmental change of vasopressin V1A and V2 receptor mRNA in rats
Hirasawa, A., Hashimoto, K., & Tsujimoto, G. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90226-7 · Cited by 78
The role of the vasopressin 1b receptor in aggression and other social behaviours
CALDWELL, H., WERSINGER, S., & YOUNGIII, W. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00406-8 · Cited by 64
Caldwell, H. K. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4614-1704-0_12 · Cited by 58
Levasseur, G., Baly, C., Grébert, D., Durieux, D., Salesse, R., & Caillol, M. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03516.x · Cited by 28
Magnocellular vasopressin and the mechanism of “Glucocorticoid escape”
Antoni, F. A. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00422 · Cited by 26
Self-citationOxytocin, vasopressin and their interplay with gonadal steroids
Dhakar, M. B., Stevenson, E. L., & Caldwell, H. K. (2013) · Oxytocin, Vasopressin and Related Peptides in the Regulation of Behavior · doi:10.1017/cbo9781139017855.003 · Cited by 20
Metadata
- Authors
- Antoni, F. A.
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2008-03-28
- Volume
- 39
- Issue
- 2
- Pages
- 186-188
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W2000696168
- Cited by
- 159
- References
- 0
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- karger.com/pages/terms-and-conditions (vor)
- karger.com/pages/terms-and-conditions (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.